Genetic analysis using whole-exome sequencing in pediatric chronic kidney disease: a single center's experience
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Chronic kidney disease (CKD) has various underlying causes in children. Identification of the underlying causes of CKD is important. Genetic causes comprise a significant proportion of pediatric CKD cases.Methods: In this study, we performed whole-exome sequencing (WES) to identify genetic causes of pediatric CKD. From January to June 2021, WES was performed using samples from pediatric patients with CKD of unclear etiology. Results: Genetic causes were investigated using WES in 37 patients (17 males) with pediatric CKD stages 1 (n=5), 2 (n=7), 3 (n=2), 4 (n=2), and 5 (n=21). The underlying diseases were focal segmental glomerulosclerosis (n=9), congenital anomalies of the kidney and urinary tract including reflux nephropathy (n=8), other glomerulopathies (n=7), unknown etiology (n=6), and others (n=7). WES identified genetic causes of CKD in 12 of the 37 patients (32.4%). Genetic defects were discovered in the COL4A4 (n=2), WT1 (n=2), ACTN4, CEP290, COL4A3, CUBN, GATA3, LAMA5, NUP107, and PAX2 genes. WT1 defects were found in patients whose pathologic diagnosis was membranoproliferative glomerulonephritis, and identification of CUBN defects led to discontinuation of immunosuppressive agents. Genetic diagnosis confirmed the clinical diagnosis of hypoparathyroidism, sensorineural deafness, and renal disease; Alport syndrome; and Joubert syndrome in three of the patients with CKD of unknown etiology (COL4A4 [n=2], CUBN [n=1]). Extrarenal symptoms were considered phenotypic presentations of WT1, PAX2, and CEP290 defects.Conclusions: WES provided a genetic diagnosis that confirmed the clinical diagnosis in a significant proportion (32.4%) of patients with pediatric CKD.
Abstract
Purpose: Chronic kidney disease (CKD) has various underlying causes in children. Identification of the underlying causes of CKD is important. Genetic causes comprise a significant proportion of pediatric CKD cases.Methods: In this study, we performed whole-exome sequencing (WES) to identify genetic causes of pediatric CKD. From January to June 2021, WES was performed using samples from pediatric patients with CKD of unclear etiology. Results: Genetic causes were investigated using WES in 37 patients (17 males) with pediatric CKD stages 1 (n=5), 2 (n=7), 3 (n=2), 4 (n=2), and 5 (n=21). The underlying diseases were focal segmental glomerulosclerosis (n=9), congenital anomalies of the kidney and urinary tract including reflux nephropathy (n=8), other glomerulopathies (n=7), unknown etiology (n=6), and others (n=7). WES identified genetic causes of CKD in 12 of the 37 patients (32.4%). Genetic defects were discovered in the COL4A4 (n=2), WT1 (n=2), ACTN4, CEP290, COL4A3, CUBN, GATA3, LAMA5, NUP107, and PAX2 genes. WT1 defects were found in patients whose pathologic diagnosis was membranoproliferative glomerulonephritis, and identification of CUBN defects led to discontinuation of immunosuppressive agents. Genetic diagnosis confirmed the clinical diagnosis of hypoparathyroidism, sensorineural deafness, and renal disease; Alport syndrome; and Joubert syndrome in three of the patients with CKD of unknown etiology (COL4A4 [n=2], CUBN [n=1]). Extrarenal symptoms were considered phenotypic presentations of WT1, PAX2, and CEP290 defects.Conclusions: WES provided a genetic diagnosis that confirmed the clinical diagnosis in a significant proportion (32.4%) of patients with pediatric CKD.
참고문헌 (31)
- Becherucci F, "Chronic kidney disease in children", Clin Kidney J, 9, pp.583~591 (2016)
- Kaspar CD, "A review of pediatric chronic kidney disease", Blood Purif, 41, pp.211~217 (2016)
- Moreira JM, "Anxiety, depression, resilience and quality of life in children and adolescents with pre-dialysis chronic kidney disease", Pediatr Nephrol, 30, pp.2153~2162 (2015)
- Al-Uzri A, "The impact of short stature on health-related quality of life in children with chronic kidney disease", J Pediatr, 163, pp.736~741 (2013)
- Gerson A, "Anemia and health-related quality of life in adolescents with chronic kidney disease", Am J Kidney Dis, 44, pp.1017~1023 (2004)
- Chen J, "Diagnostic and clinical utility of genetic testing in children with kidney failure", Pediatr Nephrol, 36, pp.3653~3662 (2021)
- Vivante A, "Exploring the genetic basis of early-onset chronic kidney disease", Nat Rev Nephrol, 12, pp.133~146 (2016)
- Devuyst O, "Rare inherited kidney diseases: challenges, opportunities, and perspectives", Lancet, 383, pp.1844~1859 (2014)
- Groopman EE, "Genomic medicine for kidney disease", Nat Rev Nephrol, 14, pp.83~104 (2018)
- Mann N, "Whole-exome sequencing enables a precision medicine approach for kidney transplant recipients", J Am Soc Nephrol, 30, pp.201~215 (2019)
- Rabbani B, "Next-generation sequencing : impact of exome sequencing in characterizing Mendelian disorders", J Hum Genet, 57, pp.621~632 (2012)
- Lee H, "Clinical exome sequencing for genetic identification of rare Mendelian disorders", JAMA, 312, pp.1880~1887 (2014)
- Yang Y, "Clinical whole-exome sequencing for the diagnosis of mendelian disorders", N Engl J Med, 369, pp.1502~1511 (2013)
- Dixon-Salazar TJ, "Exome sequencing can improve diagnosis and alter patient management", Sci Transl Med, 4, pp.138ra78~ (2012)
- Bamshad MJ, "Exome sequencing as a tool for Mendelian disease gene discovery", Nat Rev Genet, 12, pp.745~755 (2011)
- Goldstein DB, "Sequencing studies in human genetics : design and interpretation", Nat Rev Genet, 14, pp.460~470 (2013)
- Katsanis SH, "Molecular genetic testing and the future of clinical genomics", Nat Rev Genet, 14, pp.415~426 (2013)
- Bierzynska A, "Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management", Kidney Int, 91, pp.937~947 (2017)
- Bekheirnia MR, "Whole-exome sequencing in the molecular diagnosis of individuals with congenital anomalies of the kidney and urinary tract and identification of a new causative gene", Genet Med, 19, pp.412~420 (2017)
- Seo GH, "Diagnostic yield and clinical utility of whole exome sequencing using an automated variant prioritization system, EVIDENCE", Clin Genet, 98, pp.562~570 (2020)
- Richards S, "Standards and guidelines for the interpretation of sequence variants : a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology", Genet Med, 17, pp.405~424 (2015)
- Boger CA, "CUBN is a gene locus for albuminuria", J Am Soc Nephrol, 22, pp.555~570 (2011)
- Manickam K, "Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability : an evidence-based clinical guideline of the American College of Medical Genetics and Genomics(ACMG)", Genet Med, 23, pp.2029~2037 (2021)
- Deignan JL, "Points to consider in the reevaluation and reanalysis of genomic test results : a statement of the American College of Medical Genetics and Genomics(ACMG)", Genet Med, 21, pp.1267~1270 (2019)
- RENINE annual report 2015, "Hoekstra T", Nederlandse Federatie voor Nefrologie, ~ (2017)
- Lata S, "Whole-exome sequencing in adults with chronic kidney disease : a pilot study", Ann Intern Med, 168, pp.100~109 (2018)
- van der Ven AT, "Whole-exome sequencing identifies causative mutations in families with congenital anomalies of the kidney and urinary tract", J Am Soc Nephrol, 29, pp.2348~2361 (2018)
- Baum MA, "Outcome of renal transplantation in adolescents with focal segmental glomerulosclerosis", Pediatr Transplant, 6, pp.488~492 (2002)
- Malone AF, "Rare hereditary COL4A3", COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis, 2014, pp.86, 1253~1259
- Deltas C, "Carriers of autosomal recessive Alport syndrome with thin basement membrane nephropathy presenting as focal segmental glomerulosclerosis in later life", Nephron, 130, pp.271~280 (2015)
- Gast C, "Collagen(COL4A)mutations are the most frequent mutations underlying adult focal segmental glomerulosclerosis", Nephrol Dial Transplant, 31, pp.961~970 (2016)